Smartwatches may help measure autism treatment effects
NCT ID NCT04805957
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small pilot study aims to see if digital biomarkers—like heart rate and movement tracked by a watch—can help measure changes in autism symptoms during treatment with sulforaphane, a compound found in vegetables. Ten males aged 13-30 with autism who previously took part in a sulforaphane study will wear non-invasive sensors. The goal is to see if these digital tools can complement standard rating scales used in autism trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rutgers-RWJMS Department of Neurology
Piscataway, New Jersey, 08854, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gentle massage and calming sounds: a new bedtime ritual for autistic kids?
- Can a camera catch autism signs in preemie toddlers?
- Light-Up training pods may sharpen reflexes in autistic teen athletes
- Could online coaching for parents boost autistic Children's social skills?
- Can a new curriculum help autistic adults navigate romance?
- Could a phone app help parents of kids with special needs thrive?